- Home
- LVO vs ACHV Comparison
LVO vs ACHV Comparison
Compare LVO & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVO
- ACHV
- Stock Information
- Founded
- LVO 2009
- ACHV N/A
- Country
- LVO United States
- ACHV United States
- Employees
- LVO N/A
- ACHV N/A
- Industry
- LVO Restaurants
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- LVO Consumer Discretionary
- ACHV Health Care
- Exchange
- LVO Nasdaq
- ACHV Nasdaq
- Market Cap
- LVO 72.9M
- ACHV 72.5M
- IPO Year
- LVO N/A
- ACHV N/A
- Fundamental
- Price
- LVO $0.75
- ACHV $2.31
- Analyst Decision
- LVO Strong Buy
- ACHV Strong Buy
- Analyst Count
- LVO 1
- ACHV 3
- Target Price
- LVO $1.50
- ACHV $14.33
- AVG Volume (30 Days)
- LVO 935.9K
- ACHV 1.3M
- Earning Date
- LVO 08-12-2025
- ACHV 08-12-2025
- Dividend Yield
- LVO N/A
- ACHV N/A
- EPS Growth
- LVO N/A
- ACHV N/A
- EPS
- LVO N/A
- ACHV N/A
- Revenue
- LVO $114,405,000.00
- ACHV N/A
- Revenue This Year
- LVO N/A
- ACHV N/A
- Revenue Next Year
- LVO $23.84
- ACHV N/A
- P/E Ratio
- LVO N/A
- ACHV N/A
- Revenue Growth
- LVO N/A
- ACHV N/A
- 52 Week Low
- LVO $0.55
- ACHV $1.84
- 52 Week High
- LVO $1.82
- ACHV $5.31
- Technical
- Relative Strength Index (RSI)
- LVO 47.15
- ACHV 39.39
- Support Level
- LVO $0.76
- ACHV $2.02
- Resistance Level
- LVO $0.92
- ACHV $3.90
- Average True Range (ATR)
- LVO 0.07
- ACHV 0.26
- MACD
- LVO -0.00
- ACHV -0.10
- Stochastic Oscillator
- LVO 34.78
- ACHV 17.37
About LVO LiveOne Inc.
LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.